Clinical Trial Update: Bevacizumab in Combination With Verteporfin Reduced and Standard Fluence in the Treatment of Hemorrhaged Lesions in Neovascular AMD [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating Bevacizumab in combination with Verteporfin at reduced and standard fluence for hemorrhaged lesions in neovascular age-related macular …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Age-related Macular Degeneration

Drugs mentioned

• Avastin (bevacizumab)
• Visudyne (verteporfin)

Snippet

Sponsor: Vitreous -Retina- Macula Consultants of New York | Conditions: Macular Degeneration | Phase 1 | Status: TERMINATED